IL4 and chronic myelogenous leukemia, BCR-ABL1 positive: In accordance with this view, we recently demonstrated a functional deficiency of IL-4 production by iNKT cells in CML patients at diagnosis and its partial restoration in patients having achieved remission after TKI therapy (22).